Psoriasis: a continuing challenge for phototherapy.
Reusch
M
M
Christophers
E
E
D001095:Arachidonic Acids / Q000502:physiology; D003432:Cross-Linking Reagents / Q000494:pharmacology; D004247:DNA / Q000378:metabolism / Q000528:radiation effects; D011564:Furocoumarins / Q000378:metabolism; D006801:Humans; D007801:Langerhans Cells / Q000187:drug effects / Q000528:radiation effects; D008212:Lymphocyte Depletion; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D011701:PUVA Therapy; D011506:Proteins / Q000378:metabolism / Q000528:radiation effects; D011565:Psoriasis / Q000188:drug therapy* / Q000532:radiotherapy; D012313:RNA / Q000378:metabolism / Q000528:radiation effects; D012867:Skin / Q000187:drug effects / Q000528:radiation effects; D013601:T-Lymphocytes / Q000187:drug effects / Q000528:radiation effects; D014467:Ultraviolet Therapy
D001095:Arachidonic Acids; D003432:Cross-Linking Reagents; D011564:Furocoumarins; D011506:Proteins; D012313:RNA; D004247:DNA